Bank of New York Mellon’s Decoy Therapeutics DCOY Stock Holding History

Bank of New York Mellon’s Portfolio DCOY Stock Details DCOY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1	Closed	-$7K	–	4545
2022 Q3	$7K	Hold	1	–	–	﹤0.01%	4524
2022 Q2	$7K	Hold	1	–	–	﹤0.01%	4567
2022 Q1	$14K	Hold	1	–	–	﹤0.01%	4630
2021 Q4	$18K	Hold	1	–	–	﹤0.01%	4592
2021 Q3	$36K	Hold	1	–	–	﹤0.01%	4473
2021 Q2	$38K	Hold	1	–	–	﹤0.01%	4356
2021 Q1	$62K	Hold	1	–	–	﹤0.01%	4230
2020 Q4	$41K	Hold	1	–	–	﹤0.01%	4166
2020 Q3	$38K	Hold	1	–	–	﹤0.01%	4047
2020 Q2	$59K	Hold	1	–	–	﹤0.01%	3964
2020 Q1	$31K	Buy	+1	New	+$60.9K	﹤0.01%	4021
2019 Q2	–	Hold	0	–	-$5K	–	4271
2019 Q1	–	Hold	0	–	–	–	4203
2018 Q4	–	Hold	0	–	–	–	4215
2018 Q3	–	Hold	0	–	–	–	4236
2018 Q2	–	Hold	0	–	–	–	4195
2018 Q1	–	Hold	0	–	–	–	4105
2017 Q4	–	Hold	0	–	–	–	4219
2017 Q3	–	Hold	0	–	–	–	4118
2017 Q2	–	Hold	0	–	–	–	4132
2017 Q1	–	Hold	0	–	–	–	3899
2016 Q4	–	Hold	0	–	–	–	3872
2016 Q3	–	Hold	0	–	–	–	3568
2016 Q2	–	Hold	0	–	–	–	3610
2016 Q1	–	Hold	0	–	–	–	3592
2015 Q4	–	Hold	0	–	–	–	3531
2015 Q3	–	Hold	0	–	–	–	3658
2015 Q2	–	Hold	0	–	–	–	3589
2015 Q1	–	Hold	0	–	–	–	3568

Other funds holding DCOY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of New York Mellon's DCOY Position: Q4 2022 in Review

Bank of New York Mellon sold out of Decoy Therapeutics (DCOY) in Q4 2022, closing a stake of 1 share — an estimated $7K sold.

Bank of New York Mellon first reported a position in DCOY in Q1 2020 and held it in 11 quarters. The position peaked at $62K in Q1 2021. 4 funds tracked by Wall St. Rank hold DCOY as of Q4 2022.

Bank of New York Mellon reported no remaining Decoy Therapeutics position as of Q4 2022 after selling out during the quarter.
Bank of New York Mellon sold 1 Decoy Therapeutics share in Q4 2022, an estimated $7K.
Bank of New York Mellon first reported a position in Decoy Therapeutics in Q1 2020 and held it in 11 quarters.
Bank of New York Mellon's Decoy Therapeutics position peaked at $62K in Q1 2021.
4 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q4 2022.

Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.